Treace Medical Concepts (TMCI) Stock Forecast: StockMap's 2-Week Call

TMCI stock forecast: StockMap's model makes no two-week call on Treace Medical Concepts after the Nov 19 close: its evidence is split, 4 reasons for and 11 against. Right in 3 of 6 two-week windows on TMCI since Aug 21; by chance, a call on the same dates was right 58% of the time.

Treace Medical Concepts last closed at $4.35, -3.97% on the session.

Against the IVW growth benchmark the position is -1.64% over the forecast window.

Treace Medical Concepts' market cap is $285.20M as of November 19, 2026.

No call today: the model sees no clear direction · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is -8 (too close to call).

Where TMCI sits: sized by market cap, coloured by the day's move.

The read is built from 15 underlying insights — 4 bullish and 11 bearish.

Agreement across those insights is 73%.

45 daily calls for TMCI so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Treace Medical Concepts in the 13th percentile on return on equity, where 100 is best.

Treace Medical Concepts is classified under Health Care / Health Care Equipment & Supplies.

StockMap tracks Treace Medical Concepts as the 83rd largest of the 141 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 69 Neutral, 55 Moderate Underperform, 14 Strong Underperform and 3 Moderate Outperform.

On that composite Treace Medical Concepts ranks 50th of 141 in the group, against a group median of -0.18.

Other Health Care stocks

Research and education, not investment advice. The calls on this page come from StockMap's automated model, run on the close of November 19, 2026, and are the same for every reader. Calls are graded in public, misses included: how calls are graded, and the record. Who makes the calls and who pays for the site: Disclosures.

Treace Medical Concepts (TMCI) — StockMap 2-week forecast & tracked accuracy